AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min chapter
Microdosing GLP-1 and Cagrisema headlines
Docs Who Lift
Intro
This chapter explores the latest developments in weight loss medications, particularly focusing on semaglutide and terzipatide alongside a new triple agonist. The discussion also covers Novo Nordisk's stock fluctuations and the competitive dynamics within the pharmaceutical industry impacting clinical practices and patient care.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode